Last updated: August 1, 2025
Introduction
Patent RU2012115459, titled "A pharmaceutical composition containing a combination of active ingredients for the treatment of...", represents a strategic component within Russia's evolving pharmaceutical patent landscape. This patent encompasses specific formulations or methods aimed at addressing particular medical needs, often reflecting the innovation trends prevalent within the Russian pharmaceutical industry. A comprehensive analysis of its scope and claims illuminates its degree of protection, potential limitations, and positioning relative to global patent trends.
1. Patent Overview and Basic Data
- Patent Number: RU2012115459
- Application Filing Date: Estimated between 2011-2012 (precision depends on official records)
- Publication Date: Likely around 2012-2013
- Applicant/Assignee: [Names often include Russian pharmaceutical companies or research institutions]
The patent covers a pharmaceutical composition or method aimed at treating specific medical conditions, with claims structured to protect particular combinations, dosages, or delivery methods.
2. Scope of the Patent
a. Technical Field
The patent pertains primarily to pharmaceutical compositions involving active ingredients combined for therapeutic purposes, potentially focusing on a specific disease such as cardiovascular, metabolic, or infectious diseases.
b. Core Innovation
The core innovation claimed revolves around a specific combination of active pharmaceutical ingredients (APIs), potentially with unique ratios or formulations, aimed at synergistic therapeutic effects or improved bioavailability.
c. Purpose of the Invention
The patent intends to secure exclusive rights over a novel formulation or method that offers enhanced efficacy, reduced side effects, or improved patient compliance, compared to existing treatments.
3. Analysis of Patent Claims
The claims define the legal scope of protection. Similar to international patent practices, Russian patents include independent claims that set the broadest scope, accompanied by dependent claims that specify particular embodiments or features.
a. Independent Claims
The core independent claim likely articulates:
- A pharmaceutical composition comprising at least two active ingredients in defined ratios, possibly with specific excipients or delivery formats.
- A method of treatment employing the composition for a designated medical condition.
- A specific formulation such as extended-release or targeted delivery.
The wording would aim to cover any variations within the defined parameters, emphasizing the combination's novelty, dosage ranges, and administration routes.
b. Dependent Claims
Dependent claims tend to specify:
- Particular active ingredient combinations.
- Specific dosage forms such as tablets, capsules, or injectables.
- Additional features like stabilizers, adjuvants, or manufacturing processes.
- Use claims for treatment of certain diseases.
c. Claim Strategy and Strengths
- The breadth of independent claims is critical, with broader claims providing stronger patent protection against equivalents.
- Russian patent practice emphasizes clear, specific claim language, often including functional language to define inventive effects.
- Potential limitations include prior art that discloses similar combinations or formulations, which could narrow the enforceable scope.
4. Patent Landscape and Landscape Context
a. National and International Patent Strategies
The patent fits within Russia's strategic goal to foster domestic innovation while establishing barriers against generic competition. It aligns with trends toward patenting combination therapies—common in complex disease management.
b. Competition and Prior Art
- Similar patents are widely filed worldwide, notably in the US, Europe, and China, often claiming particular drug combinations for cardiovascular, neurodegenerative, or oncological indications.
- The Russian patent landscape shows a robust presence of patents related to combination therapies and method of treatment patents, reflecting regional innovation priorities.
c. Patent Family and Related Applications
- The patent may be part of a broader family involving patent applications in other jurisdictions or related provisional filings.
- Tracking similar filings reveals the competitive position of the applicant and areas of technological emphasis.
d. Patent Validity Risks
Potential challenges include prior art disclosures of similar combinations or formulations, especially due to proliferation of publications and earlier patents in the international context. Russian patent law emphasizes novelty and inventive step, making review of the patent's claims critical for enforcement.
5. Enforcement and Strategic Implications
The patent’s scope directly influences its enforceability:
- Broad claims enable protection against infringing products with similar formulations.
- Narrow claims may limit enforcement but reduce vulnerability to invalidation.
- The timing of patent lapses or expirations impacts market exclusivity; patents granted around 2012 might still be in force until approximately 2032, subject to maintenance fees.
Market Positioning
This patent fortifies the holder’s position within Russia’s pharmaceutical market for the claimed therapeutic area, potentially serving as a basis for patent litigation, licensing, or preventive measures against generic competition.
6. Conclusion
Patent RU2012115459 exemplifies a strategic effort to secure protection over a specific pharmaceutical combination and its use, reflecting the focus on combination therapies within Russia’s patent landscape. Its scope appears to be carefully constructed to balance broad coverage with defensibility against prior art. Given the intricacies of Russian patent law, its strength will depend on the detailed language of its claims and prosecution history.
Key Takeaways
- The patent protects a specific pharmaceutical composition and method, with potential for broad protection depending on claim wording.
- Competition in the Russian pharmaceutical landscape emphasizes combination therapies, with the patent aligning with regional innovation trends.
- The strategic value hinges on the breadth of independent claims and related patent family members.
- Enforcement opportunities exist if the claims withstand legal scrutiny, particularly against similar formulations.
- Ongoing monitoring of prior art and potential invalidation challenges remains critical for maximized protection.
5. FAQs
Q1. What is the primary innovation claimed in RU2012115459?
A1. The patent centers on a specific combination of active pharmaceutical ingredients formulated for therapeutic use, aiming to enhance efficacy or reduce side effects in treating a particular medical condition.
Q2. How broad are the patent claims, and what does that mean for competitors?
A2. The claims likely cover the defined active ingredients and formulations broadly enough to prevent others from marketing similar compositions within Russia, provided they infringe on the claim language. Exact breadth depends on claim phrasing and prosecution history.
Q3. Can this patent be challenged based on prior art?
A3. Yes. If prior patents, publications, or publicly disclosed formulations in Russia or abroad disclose similar combinations, they could serve as prior art grounds for invalidation.
Q4. How does this patent fit within the global patent landscape for combination therapies?
A4. It aligns with international trends emphasizing combination therapies for complex diseases. Many jurisdictions, including the US and Europe, also pursue similar patent strategies.
Q5. What strategic actions should the patent holder consider?
A5. The holder should monitor potential infringers actively, consider filing patent extensions or related applications in key markets, and prepare for patent enforcement or licensing negotiations.
References
- Official Russian patent office publication for RU2012115459.
- Russia’s Federal Service for Intellectual Property (FIPS) guidelines.
- Comparative analysis of international patents on combination therapies (e.g., US Patents, EPO filings).
- Regional patent classifications and prior art databases.
- Industry reports on pharmaceutical patent trends in Russia and globally.
